BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//hacksw/handcal//NONSGML v1.0//EN
BEGIN:VEVENT
UID:2007432d0c48f83b9241492d6d6af724
DTSTAMP:20260604T015156Z
DTSTART:20171130T090000
DTEND:20171201T180000
SUMMARY:22nd Global Vaccines & Vaccination Summit
DESCRIPTION:Theme: Innovative Therapeutic Strategies in Vaccines & Vaccination\n\nTrack 1: Vaccine development:\nVaccine research is long, complex and costly. Because a vaccine is a biological product made from living microorganisms, its development method is quite different from that of a pharmaceutical method. Approximately 70% of production time is dedicated to quality control, Vaccine development is a long, complex process, often lasting 10-15 years and involving a combination of public and private involvement. Vaccine development and testing follow a standard set of steps.\n1. Laboratory Studies and Animal Studies: Exploratory Stage, Pre-clinical Stage, IND Application\n2. Clinical Studies with Human Subjects: Phase I Vaccine Trials, Phase II Vaccine Trials, Phase III Vaccine Trials,\n3. Approval and Licensure\n4. Post-Licensure Monitoring of Vaccines\n5. Phase IV Trials\n\nVAERS: The Vaccine Adverse Event Reporting System\n\n\nTrack 2: Vaccine Business:\n\nThe Evolution in the Vaccines market continues with strong growth and new prospects to continue the growth in Vaccines market, which now stands at about $25 billion. The market is expected to return a compound annual growth rate of more than 8% through 2018, Evaluate projects, with some segments like adult vaccines showing even better.
X-ALT-DESC;FMTTYPE=text/html:\n\n\n\n\n\n\n\n\nTheme: Innovative Therapeutic Strategies in Vaccines & Vaccination
Track 1: Vaccine development:
Vaccine research is long, complex and costly. Because a vaccine is a biological product made from living microorganisms, its development method is quite different from that of a pharmaceutical method. Approximately 70% of production time is dedicated to quality control, Vaccine development is a long, complex process, often lasting 10-15 years and involving a combination of public and private involvement. Vaccine development and testing follow a standard set of steps.
1. Laboratory Studies and Animal Studies: Exploratory Stage, Pre-clinical Stage, IND Application
2. Clinical Studies with Human Subjects: Phase I Vaccine Trials, Phase II Vaccine Trials, Phase III Vaccine Trials,
3. Approval and Licensure
4. Post-Licensure Monitoring of Vaccines
5. Phase IV Trials
VAERS: The Vaccine Adverse Event Reporting System
Track 2: Vaccine Business:
The Evolution in the Vaccines market continues with strong growth and new prospects to continue the growth in Vaccines market, which now stands at about $25 billion. The market is expected to return a compound annual growth rate of more than 8% through 2018, Evaluate projects, with some segments like adult vaccines showing even better.\n\n\n
LOCATION:Dubai - United Arab Emirates
END:VEVENT
END:VCALENDAR